Matches in SemOpenAlex for { <https://semopenalex.org/work/W2887360343> ?p ?o ?g. }
- W2887360343 endingPage "379" @default.
- W2887360343 startingPage "368" @default.
- W2887360343 abstract "Abstract Human epidermal growth factor receptor 2 (HER2)-positive is an aggressive subtype of breast cancer and has historically been associated with poor outcomes. The availability of various anti-HER2 therapies, including trastuzumab, lapatinib, pertuzumab, and trastuzumab emtansine (TDM-1), has remarkably improved the clinical outcomes in patients with HER2-positive metastatic breast cancer (mBC). However, there is a need to optimize treatment within this population, given the wide variability in clinical presentation. Additionally, geographical and socio-economic considerations too need to be taken into account. To clarify and collate evidence pertaining to HER2-positive metastatic breast cancer, a panel of medical and clinical oncologists from across India developed representative clinical scenarios commonly encountered in clinical practice in the country. This was followed by two meetings wherein each clinical scenario was discussed in detail and relevant evidence appraised. The result of this process is presented in this manuscript as evidence followed by therapeutic recommendations of this panel for management of HER2-positive mBC in the Indian population." @default.
- W2887360343 created "2018-08-22" @default.
- W2887360343 creator A5002995682 @default.
- W2887360343 creator A5003994970 @default.
- W2887360343 creator A5004596662 @default.
- W2887360343 creator A5007558296 @default.
- W2887360343 creator A5011569185 @default.
- W2887360343 creator A5021494007 @default.
- W2887360343 creator A5026063031 @default.
- W2887360343 creator A5032099452 @default.
- W2887360343 creator A5033627353 @default.
- W2887360343 creator A5033932153 @default.
- W2887360343 creator A5035846372 @default.
- W2887360343 creator A5041874883 @default.
- W2887360343 creator A5048413992 @default.
- W2887360343 creator A5055220224 @default.
- W2887360343 creator A5056728776 @default.
- W2887360343 creator A5061045204 @default.
- W2887360343 creator A5064588191 @default.
- W2887360343 creator A5067455502 @default.
- W2887360343 creator A5073534978 @default.
- W2887360343 creator A5075866402 @default.
- W2887360343 creator A5076171969 @default.
- W2887360343 creator A5076600103 @default.
- W2887360343 creator A5077979168 @default.
- W2887360343 creator A5082879632 @default.
- W2887360343 creator A5084045330 @default.
- W2887360343 creator A5085119469 @default.
- W2887360343 creator A5087898601 @default.
- W2887360343 date "2018-07-01" @default.
- W2887360343 modified "2023-10-01" @default.
- W2887360343 title "Current Treatment Options for Human Epidermal Growth Factor Receptor 2-Directed Therapy in Metastatic Breast Cancer: An Indian Perspective" @default.
- W2887360343 cites W1964554229 @default.
- W2887360343 cites W1975208701 @default.
- W2887360343 cites W1976446970 @default.
- W2887360343 cites W2000798782 @default.
- W2887360343 cites W2012784647 @default.
- W2887360343 cites W2063376924 @default.
- W2887360343 cites W2081924473 @default.
- W2887360343 cites W2089605820 @default.
- W2887360343 cites W2101824720 @default.
- W2887360343 cites W2103808574 @default.
- W2887360343 cites W2109176076 @default.
- W2887360343 cites W2110444464 @default.
- W2887360343 cites W2115175878 @default.
- W2887360343 cites W2120627364 @default.
- W2887360343 cites W2125401809 @default.
- W2887360343 cites W2127714076 @default.
- W2887360343 cites W2134031795 @default.
- W2887360343 cites W2137228442 @default.
- W2887360343 cites W2141393790 @default.
- W2887360343 cites W2148479421 @default.
- W2887360343 cites W2152872485 @default.
- W2887360343 cites W2159967578 @default.
- W2887360343 cites W2161977537 @default.
- W2887360343 cites W2162901058 @default.
- W2887360343 cites W2166199281 @default.
- W2887360343 cites W2166656480 @default.
- W2887360343 cites W2168372454 @default.
- W2887360343 cites W2170241131 @default.
- W2887360343 cites W2175378170 @default.
- W2887360343 cites W2251611718 @default.
- W2887360343 cites W2318605753 @default.
- W2887360343 cites W2338970534 @default.
- W2887360343 cites W2345111626 @default.
- W2887360343 cites W2361089382 @default.
- W2887360343 cites W2551315898 @default.
- W2887360343 cites W2571310200 @default.
- W2887360343 cites W2596461556 @default.
- W2887360343 cites W2609953159 @default.
- W2887360343 cites W2628334655 @default.
- W2887360343 cites W3011682923 @default.
- W2887360343 cites W2593491536 @default.
- W2887360343 doi "https://doi.org/10.4103/ijmpo.ijmpo_201_17" @default.
- W2887360343 hasPublicationYear "2018" @default.
- W2887360343 type Work @default.
- W2887360343 sameAs 2887360343 @default.
- W2887360343 citedByCount "1" @default.
- W2887360343 countsByYear W28873603432023 @default.
- W2887360343 crossrefType "journal-article" @default.
- W2887360343 hasAuthorship W2887360343A5002995682 @default.
- W2887360343 hasAuthorship W2887360343A5003994970 @default.
- W2887360343 hasAuthorship W2887360343A5004596662 @default.
- W2887360343 hasAuthorship W2887360343A5007558296 @default.
- W2887360343 hasAuthorship W2887360343A5011569185 @default.
- W2887360343 hasAuthorship W2887360343A5021494007 @default.
- W2887360343 hasAuthorship W2887360343A5026063031 @default.
- W2887360343 hasAuthorship W2887360343A5032099452 @default.
- W2887360343 hasAuthorship W2887360343A5033627353 @default.
- W2887360343 hasAuthorship W2887360343A5033932153 @default.
- W2887360343 hasAuthorship W2887360343A5035846372 @default.
- W2887360343 hasAuthorship W2887360343A5041874883 @default.
- W2887360343 hasAuthorship W2887360343A5048413992 @default.
- W2887360343 hasAuthorship W2887360343A5055220224 @default.
- W2887360343 hasAuthorship W2887360343A5056728776 @default.
- W2887360343 hasAuthorship W2887360343A5061045204 @default.
- W2887360343 hasAuthorship W2887360343A5064588191 @default.
- W2887360343 hasAuthorship W2887360343A5067455502 @default.